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Abstract
Parthenogenetic embryos are one attractive alternative as a source of embryonic stem cells, although many aspects related
to the biology of parthenogenetic embryos and parthenogenetically derived cell lines still need to be elucidated. The
present work was conducted to investigate the gene expression profile of rabbit parthenote embryos cultured under in vivo
conditions using microarray analysis. Transcriptomic profiles indicate 2541 differentially expressed genes between
parthenotes and normal in vivo fertilised blastocysts, of which 76 genes were upregulated and 16 genes downregulated in
in vivo cultured parthenote blastocyst, using 3 fold-changes as a cut-off. While differentially upregulated expressed genes
are related to transport and protein metabolic process, downregulated expressed genes are related to DNA and RNA
binding. Using microarray data, 6 imprinted genes were identified as conserved among rabbits, humans and mice: GRB10,
ATP10A, ZNF215, NDN, IMPACT and SFMBT2. We also found that 26 putative genes have at least one member of that gene
family imprinted in other species. These data strengthen the view that a large fraction of genes is differentially expressed
between parthenogenetic and normal embryos cultured under the same conditions and offer a new approach to the
identification of imprinted genes in rabbit.
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Introduction
Embryonic stem cells (ESCs) have enormous potential in
biomedicine for cell replacement, drug screening, predictive
toxicology and developmental studies [1] and are envisaged as a
powerful source of pluripotent cells for differentiation into
desirable tissue for regenerative medicine and cell therapy [2,3].
Despite the tremendous potential of ESCs, their handicap is the
isolation method, as they are obtained from the inner cell mass of a
blastocyst, making the embryo unviable [4].
Parthenogenetic embryos are being studied as an alternative
source of ESCs, which would avoid ethical concerns related to
destruction of the embryo [4,5]. ESCs derived from parthenoge-
netic embryos (pESCs) have been shown to differentiate into all
cell types and functional organs in the body [6]. However, several
studies have evaluated similarities and differences between
parthenogenetic and conventional ESCs in pluripotency, karyo-
type, in vivo and in vitro differentiation ability and RNA expression
levels in human, nonhuman primates and rabbit [1,2,3,5,7,8].
Generally, they present normal karyotypes and are similar in their
undifferentiated state, expressing normal pluripotency markers,
but present different transcriptomes, with different expression
patterns of extracellular matrix proteins and methylation.
In rabbit, ESCs lines from different origin have been derived
and characterised [8,9]. Fang et al. [8] showed that ESCs derived
from fertilised, parthenogenetic and nuclear transfer embryos
seem to be similar, in that all three types were able to give rise to
cells and tissue types of the three primary germ layers when ESCs
are cultured in vivo and in vitro. In this case, ESCs of
parthenogenetic and nuclear transfer embryos were derived using
the same protocol. However, the origin of the source of the cell
line has important consequences [1]. Piedrahita et al. [10] showed
that ESCs lines from mice and pigs derived with the same protocol
have some similar characteristics, but not all. Under in vitro culture,
parthenote embryos present altered mRNA expression patterns,
while in vivo developed parthenotes seem to be similar to normal
embryos for the expression of factor OCT-4, Vascular Endothelial
Growth Factor, Epidermal Growth Factor Receptor 3 and
Transforming Growth Factor b2 genes [11]. In fact, in parthenote
embryos the maximum development reached in all mammals
species has been reported when embryos were transferred to
subrogate females in early stages of development, providing a large
in vivo culture.
In the present work, we employed a microarray to characterise
transcriptome differences between 6-day parthenote embryos and
6-day fertilised blastocysts developed in vivo. In addition, based on
the list of candidate genes identified by microarray, we studied the
expression levels of selected transcripts in the parthenotes and
fertilised blastocyst derived in vivo and checked this list with a
database of genes previously listed as imprinted, while also
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reporting the identification of putative imprinted genes in rabbit
blastocysts.
Materials and Methods
All chemicals in this study were purchased from Sigma-Aldrich
Quı´mica S.A. (Madrid, Spain) unless stated otherwise.
Animals
Mature (adult) rabbit does belonging to the New Zealand White
line from the ICTA (Instituto de Ciencia y Tecnologı´a Animal) at
the Polytechnic University of Valencia (Spain) were used as oocyte
and embryo donors and recipient does. The Ethics and Animal
Welfare Committee of the Universidad Polite´cnica de Valencia
approved this study. All animals were handled according to the
principles of animal care published by Spanish Royal Decree
1201/2005 (BOE, 2005; BOE=Official Spanish State Gazette).
Parthenogenetic oocyte activation
To obtain oocytes for parthenogenetic activation, 32 receptive
does were induced to ovulate with an intramuscular dose of 1 mg
of Buserelin acetate. Does were slaughtered 16–18 h post-
induction of ovulation and the reproductive tract was immediately
removed. Oocytes were recovered by perfusion of each oviduct
with 5 mL of pre-warmed Phosphate Buffered Saline without
calcium chloride (PBS) and supplemented with 0.1% of Bovine
Serum Albumin (BSA). Recovered oocytes were submitted to two
sets 1 h apart of two DC electrical pulses of 3.2 kv/cm for 20 ms at
1 sec apart in an activation medium (0.3 M mannitol supple-
mented with 100 mM MgSO4 and 100 mM CaCl2), followed by
1 h exposure in TCM199 medium supplemented with 5 mg/mL of
cycloheximide and 2 mM of 6-DMAP. A total of 369 oocytes were
activated.
Oviductal transfer by laparoscopy
Presumptive parthenotes were transferred by laparoscopy into
oviducts of 13 synchronised receptive does just after activation,
whose ovulation was induced as previously described [12,13].
About 28 activated oocytes per doe were transferred. Receptive
does were anaesthetised by an intramuscular injection of 16 mg
xylazine (Rompun; Bayern AG, Leverkusen, Germany), followed
by an intravenous injection of ketamine hydrochloride at the rate
of 25 mg/kg body weight (Imalgene 1000; Merial S.A, Lyon,
France) to keep does under anaesthesia during laparoscopy.
Females were slaughtered 6 days later and parthenote blastocysts
were recovered by uterine horns perfusion with 20 mL of
Dulbecco Phosphate Buffered Saline (DPBS) supplemented with
0.1% of BSA.
Control embryo recovery at day 6 of development
Six receptive does were artificially inseminated with pooled
sperm from fertile males [14] and induced to ovulate as previously
described. In vivo fertilised embryos were collected from does
slaughtered at 6 days of pregnancy by flushing uterine horns as
previously described.
RNA extraction, amplification and sample labelling
As the amount of RNA present in a single embryo is rather
limited [15], for each experimental group (parthenotes and in vivo
fertilised embryos) four independent pools consisting of seven
embryos were produced. Total RNA was isolated using traditional
phenol/chloroform extraction by sonication in the Trizol reagent
(Invitrogen). Concentration, quality and integrity of RNA were
evaluated by Bioanalyzer 2100 (Agilent Technologies). Afterwards,
150 ng of Total RNA were amplified and labelled using
QuickAmp Labelling Kit (Agilent Technologies, Madrid, Spain),
following the manufacturer’s instructions, which employs a linear
amplification method with T7 polimerase. Control embryo
samples were labelled with Cyanine 5 dye (Cy5) and parthenote
Table 1. Information on primers used for real-time qPCR.
Gene Accession number Sequence 59R39 Fragment size (pb) Efficiency (%) Correlation (R2)
IMPACT ENSOCUT00000013903 GCGTCTTCTTCACCTCATGG 116 104.8 0.99
TGTTTCTTGGCACAGTTGTTGA
SMARCA2 ENSOCUT00000006331 AATCCGCAACCACAAGTAAC 113 103.1 0.99
GAACACTGACTGTAAGACGAT
EMP1 ENSOCUT00000021095 AATGTTGGTGTTACTGGCTG 110 100.2 0.98
GATGCGTTAATAGAGTCTGAA
SCGB1A1 ENSOCUT00000014246 CCAGTTACGAGACATCCCTGA 155 93 0.99
CATACACAGTGGGCTCTTCACT
DPY30 ENSOCUT00000021095 GCAGAGAACCCTCATTCTGAG 148 98.4 0.99
CGCACAACTGTCTGATCCTGGT
CALC ENSOCUT00000003074 GCTAGAGACTGAGGGCTCCA 124 90.8 0.99
CACGAAGTTGCTCTTCACCA
H2AFZ AF030235 AGAGCCGGCTGCCAGTTCC 85 98.8 1
CAGTCGCGCCCACACGTCC
GAPDH L23961 GTTCTTCTCGTGCAG 144 93.1 1
ATGGATCATTGATGGCGACAACAT
H2AFZ: H2A histone family member Z [35]; GAPDH: glyceraldehyde-3-phosphate dehydrogenase [36]; SMARCA2: SWI/SNF related, matrix associated, actin dependent
regulator of chromatin, subfamily a, member 2; EMP1: Epithelial membrane protein 1; CALC: calcitonin gene-related peptide variant 1; SCGB1A1: secretoglobin family 1A
member 1).
doi:10.1371/journal.pone.0051271.t001
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embryo samples with Cyanine 3 dye (Cy3). Excess dye was
removed with the QIAquick PCR purification kit (QIAGEN,
Madrid, Spain) and dye incorporation and concentration were
determined using the microarray setting on the Nanodrop 1000.
Hybridisation, washing and scanning of Microarrays
Equal amounts of Cy3 and Cy5 labelled samples (825 ng) were
mixed with 106 Blocking Agent and Fragmentation Buffer, and
then 55 mL of the mixture were hybridised into the commercial
microarray specific for rabbit (Rabbit 446 oligonucleotide array;
cat: G2519F -020908, Agilent Technologies, Madrid, Spain). This
microarray was manufactured using the Agilent 60-mer SurePrint
technology, which represented sequences of Refseq, Unigene and
Ensembl databases (specifically 12083 identifiers of genes corre-
sponding to the ENSEMBL database). After 17 hours at 65uC,
hybridised slides were washed and scanned using the Agilent DNA
Microarray Scanner G2565B (Agilent Technologies, Madrid,
Spain). The resulting images were processed using the Feature
Extraction v.10 Software (Agilent Technologies, Madrid, Spain)
with default parameters. Only microarrays which passed control
quality tests of Feature Extraction Software were used in posterior
analysis.
Microarray data analysis
Filtering of problematic probes identified as flag outliers and
identification of differentially expressed genes between both
experimental groups were performed using the software Gene-
Spring v.11.5 (Agilent Technologies, Madrid, Spain). A non-
supervised analysis of global gene expression was performed using
the principal components analysis (PCA). To identify differentially
expressed genes, we used the T-test with Benjamini and Hochberg
multiple test correction implemented in the GeneSpring (Agilent
Technologies). Probe sets were considered differentially expressed
between two conditions if they had a false discovery rate (FDR) of
p-value,0.05. Gene Ontology analysis and functional annotation
of differentially expressed genes were performed by Blast2GO
software v.2.5.1 with default parameters [16]. All data sets related
to this study were deposited in NCBI’s Gene Expression Omnibus
[17] and are accessible through GEO Series accession number
GSE41043.
Real-time qPCR
To validate the microarray results obtained, six genes (IMPACT;
SMARCA2: SWI/SNF related matrix associated actin dependent
regulator of chromatin subfamily A member 2; EMP1: Epithelial
membrane protein 1; DPY30; CALC: calcitonin gene-related
peptide variant 1; SCGB1A1: secretoglobin family 1A member 1)
that showed a significant difference between experimental groups
were selected and analysed in twelve independent pool samples
(microarray samples plus additional pools). To prevent DNA
contamination, one deoxyribonuclease treatment step (gDNA
Wipeout Buffer, Qiagen Iberia S.L, Madrid, Spain) was performed
from total RNA (1000 ng). Reverse transcription was then carried
out using the Reverse Transcriptase Quantitect kit (Qiagen Iberia
Figure 1. Principal Component Analysis (PCA) of microarray data. Principal Component Analysis (PCA) of microarray data. PCA two-
dimensional scatter plot represent the differential gene expression patterns of frozen and control embryos. Axis: X = PC1: PCA Component 1 (56.75%
variance); Y = PC2: PCA Component 2 (18.17% variance).
doi:10.1371/journal.pone.0051271.g001
Table 2. Classification of differentially expressed transcript
probes based on fold changes.
p-value
Fold-change ,0.05 ,0.02 ,0.01
All 5790 881 20
.1.1 5547 870 20
.1.5 1606 363 14
.2.0 557 167 12
.3.0 199 67 8
doi:10.1371/journal.pone.0051271.t002
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Table 3. Genes upregulated by at least three-fold in parthenogenetic late blastocysts.
Gene symbol/probe Gene accession Gene name Fold-change
A_04_P030002 C84254 221,46
MECOM ENSOCUT00000010173 MDS1 and EVI1 complex locus 213,21
Q95LB3 ENSOCUT00000015946 Development promoting factor Oviductal glycoprotein 1 214,60
SAA1 NM_001082327 Serum amyloid protein A 213,32
C20orf85 ENSOCUT00000012758 Chromosome 20 open reading frame 85 211,38
MLF1 ENSOCUT00000013546 Myeloid leukaemia factor 1 210,39
RTP4 ENSOCUT00000007680 Receptor (chemosensory) transporter protein 4 29,56
SCGB1A1 NM_001082237 Secretoglobin, family 1A, member 1 (uteroglobin) 29,51
CCDC153 ENSOCUT00000016944 Coiled-coil domain containing 153 29,28
ADO ENSOCUT00000013986 Aldehyde oxidase 28,57
A_04_P017348 DN886936 28,19
SULT1E1 ENSOCUT00000005024 Sulfotransferase family 1E, oestrogen-preferring, member 1 27,54
C1orf189 ENSOCUT00000016457 Chromosome 1 open reading frame 189 27,02
S100A4 ENSOCUT00000008641 S100 calcium binding protein A4 26,20
A_04_P016580 X00412 27,46
ZBTB20 ENSOCUT00000004232 Zinc finger and BTB domain containing 20 27,45
SORBS2 ENSOCUT00000005820 Sorbin and SH3 domain containing 2 26,73
SMARCA2 ENSOCUT00000006331 SWI/SNF related, matrix associated, actin dependent regulator of Chromatin,
subfamily a, member 2
26,21
B7NZD6 ENSOCUT00000003373 Selenium binding protein 1 26,45
CCL2 NM_001082294 Chemokine (C-C motif) ligand 2 25,62
EMP1 NM_001082357 Epithelial membrane protein 1 26,07
CAPS NM_001082644 Calcyphosine 25,54
A_04_P033277 EB380127 25,79
SPINK1 ENSOCUT00000001659 Serine peptidase inhibitor, Kazal type 1 25,20
ANXA1 ENSOCUT00000015491 Annexin A1 25,13
S100A14 ENSOCUT00000002741 S100 calcium binding protein A14 25,29
CCL20 ENSOCUT00000000868 Chemokine (C-C motif) ligand 20 24,74
PLAU NM_001082011 Plasminogen activator, urokinase 25,03
C11orf70 ENSOCUT00000006101 Chromosome 11 open reading frame 70 24,91
FANK1 ENSOCUT00000008774 Fibronectin type III and ankyrin repeat domains 1 24,65
A_04_P092437 ENSOCUT00000013589 24,81
MYL4 ENSOCUT00000010827 Myosin, light chain 4, alkali; atrial, embryonic 24,81
A_04_P035022 ENSOCUT00000005248 24,73
IL1R1 NM_001082770 Interleukin 1 receptor, type I 24,54
SLC16A7 ENSOCUT00000003051 Solute carrier family 16, member 7 (monocarboxylic acid transporter 2) 24,18
A_04_P044537 ENSOCUT00000012839 24,35
CLUS ENSOCUT00000005984 ClusterinClusterin beta chain Clusterin alpha chain 24,34
NPY ENSOCUT00000010758 Neuropeptide Y 24,31
A_04_P016911 DN884335 24,24
CAV1 NM_001111072 Caveolin 1, caveolae protein 24,12
TNNI1 ENSOCUT00000010422 Troponin I, slow skeletal muscle 24,01
ARAP2 ENSOCUT00000015685 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 23,97
DYNLRB2 ENSOCUT00000008571 Dynein, light chain, roadblock-type 2 23,92
ALAS2 ENSOCUT00000013600 Aminolevulinate, delta-, synthase 2 23,85
HECW1 ENSOCUT00000008000 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 23,76
SCMC1 ENSOCUT00000012809 Calcium-binding mitochondrial carrier protein SCaMC-1 23,75
OCA2 ENSOCUT00000003517 Oculocutaneous albinism II 23,56
CTBS ENSOCUT00000003057 Chitobiase, di-N-acetyl- 23,71
A_04_P016912 DN884335 23,71
Transcriptome of In Vivo Parthenote Blastocysts
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Table 3. Cont.
Gene symbol/probe Gene accession Gene name Fold-change
A_04_P060497 ENSOCUT00000006983 23,69
GPIIIa NM_001082066 Glycoprotein IIIa 23,47
B3GS73 ENSOCUT00000007932 CCL28 23,49
CD48 ENSOCUT00000013544 CD48 molecule 23,60
LIPC ENSOCUT00000001646 Hepatic triacylglycerol lipase 23,45
GST ENSOCUT00000011951 Glutathione S-transferase 23,44
SLC25A23 NM_001082777 Solute carrier family 25 (mitochondrial carrier ; phosphate carrier),
Member 23 nuclear gene encoding mitochondrial protein
23,44
LRRIQ1 ENSOCUT00000017528 Leucine-rich repeats and IQ motif containing 1 23,43
ST3GAL5 ENSOCUT00000010127 ST3 beta-galactoside alpha-2,3-sialyltransferase 5 23,42
LMO2 ENSOCUT00000001532 LIM domain only 2 (rhombotin-like 1) 23,37
O97770 ENSOCUT00000016899 Titin 23,37
A_04_P013028 K02441 23,22
CTBS ENSOCUT00000003057 Chitobiase, di-N-acetyl- 23,32
MYL3 ENSOCUT00000012390 Myosin, light chain 3, alkali; ventricular, skeletal, slow 23,32
PPIL6 ENSOCUT00000006037 Peptidylprolyl isomerase (cyclophilin)-like 6 23,31
A_04_P033242 EH792761 23,26
SCMC1 ENSOCUT00000012809 Calcium-binding mitochondrial carrier protein SCaMC-1 23,16
A_04_P054532 ENSOCUT00000000433 23,20
GPRC5A ENSOCUT00000016550 G protein-coupled receptor, family C, group 5, member A 23,16
TTC18 ENSOCUT00000007154 Tetratricopeptide repeat domain 18 23,16
MAMDC2 ENSOCUT00000000271 MAM domain containing 2 23,16
C1RL ENSOCUT00000014491 Complement component 1, r subcomponent-like 23,15
RSPH9 ENSOCUT00000005536 Radial spoke head 9 homolog (Chlamydomonas) 23,11
A_04_P004519 ENSOCUT00000011542 23,06
A_04_P034797 ENSOCUT00000008808 23,04
Genes are tabulated in the descending order of the fold-change values. Transcripts without annotation were identified by probe set ID.
doi:10.1371/journal.pone.0051271.t003
Table 4. Genes downregulated by at least three-fold in parthenogenetic late blastocysts.
Gene/probe Gene accession Gene name Fold-change
A_04_P013564 EB375829 51,83
SNRPN NM_001082714 Small nuclear ribonucleoprotein polypeptide N 48,40
CALC ENSOCUT00000003074 Calcitonin gene-related peptide variant 1 7,54
TAC1 NM_001101698 Tachykinin, precursor 1 7,26
MS4A13 ENSOCUT00000015913 Membrane-spanning 4-domains, subfamily A, member 13 6,67
A_04_P017715 EB373964 6,55
IMPACT ENSOCUT00000013903 Protein IMPACT 4,58
KRTCAP3 ENSOCUT00000004321 Keratinocyte associated protein 3 4,35
A_04_P085877 ENSOCUT00000003190 3,58
KPB2 ENSOCUT00000013796 Phosphorylase b kinase regulatory subunit alpha, liver isoform 3,47
A_04_P035497 ENSOCUT00000016846 3,25
DPY30 ENSOCUT00000017876 Dpy-30 homolog 3,23
RIT1 ENSOCUT00000006374 Ras-like without CAAX 1 3,16
Q8SQB7 ENSOCUT00000001908 Inducible nitric oxide synthase 3,13
CXCR7 ENSOCUT00000010904 Chemokine (C-X-C motif) receptor 7 3,10
PON3 ENSOCUT00000002011 Serum paraoxonase/lactonase 3 3,07
Genes are tabulated in the descending order of the fold-change values. Transcripts without annotation were identified by probe set ID.
doi:10.1371/journal.pone.0051271.t004
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S.L, Madrid, Spain) according to the manufacturer’s instructions.
Real-time qPCR (RT-qPCR) reactions were conducted in an
Applied Biosystems 7500 (Applied Biosystems, Foster City, CA).
Every PCR was performed with 5 mL of 1/10 diluted cDNA of
each sample used in each reaction in a final volume of 20 mL of
10 mL of SYBR Green Master Mix (Applied Biosystems) and
200 nM of forward and reverse primers (list of RT-qPCR primers
is shown in Table 1). The PCR protocol included an initial step of
50uC (2 min), followed by 95uC (10 min) and 40 cycles of 95uC
(15 sec) and 60uC (1 min). After RT-qPCR, a melting curve
analysis was performed by slowly increasing the temperature from
65uC to 95uC, with continuous recording of changes in fluorescent
emission intensity. Serial dilutions of cDNA pool made from
several samples were run in triplicate to assess PCR efficiency and
decide which dilution to use for unknown samples. Target and
reference genes in unknown samples were run in duplicate. Non-
template controls (cDNA was replaced by water) for each primer
pair were run in all plates. A DDCt method adjusted for PCR
efficiency was used [18], employing the geometric average of
H2AFZ and GAPDH as normalisation factor [19] and relative
expression of cDNA pooled from various samples was used as a
calibrator. The products of RT-qPCR were confirmed by
Figure 2. Gene Ontology (GO) bar chart of differentially expressed genes between parthenotes and fertilised embryos. Gene
Ontology (GO) bar chart of differentially expressed genes between parthenotes and in vivo fertilised embryos. Genes upregulated and
downregulated in parthenotes embryos that are categorised by GO term ‘‘Biological process’’ level 4.
doi:10.1371/journal.pone.0051271.g002
Table 5. Real-time quantitative PCR assay for six randomly
selected genes.
Relative expression (a.u.) Fold change
Gene
Fertilised
embryos
Parthenote
embryos RT-qPCR Microarray
IMPACT 0.8260.16a 0.00460.21b 7.68 4.58
DPY30 1.2460.14a 0.2760.18b 2.20 3.23
CALC 0.5660.04a 0.1460.05b 2.00 7.54
SCGB1A1 0.0460.22a 1.2560.25b 24.96 29.51
EMP1 0.4861.99a 8.3761.99b 24.12 26.07
SMARCA2 0.1660.51a 1.7660.51b 23.45 26.21
SMARCA2: SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily a, member 2; EMP1: Epithelial membrane protein 1; CALC:
calcitonin gene-related peptide variant 1; SCGB1A1: secretoglobin family 1A
member 1). Relative expression values are shown in arbitrary units (a.u),
expressed by the mean value 6 standard error means. Letters with different
superscripts are significantly different (P,0.05). RT-qPCR fold changes were
obtained by calculation of log2 transformed ratio of relative expression for each
gene. Microarray fold changes were obtained by log2 transformed probe
intensities for each gene.
doi:10.1371/journal.pone.0051271.t005
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ethidium bromide-stained 2% agarose gel electrophoresis in 16
Bionic buffer.
Statistical Analysis
Data were analysed using the Statgraphics version Plus 5.1
(Statistical Graphics Co., Rockville, MD, USA,) software package.
The relative expression data were analysed using General Linear
Model (GLM). For SMARCA2 a Neperian logarithmic transfor-
mation was done before analysis for data normalisation. Differ-
ences in mean values were tested using ANOVA followed by a
multiple pair wise comparison using t-test. Differences of p,0.05
were considered to be significant.
Results
Parthenote embryo production and blastocyst recovery
From the total of 369 oocytes activated and transferred to
recipient does, 49 blastocysts properly developed were recovered
at day 6 post-activation (13.3%). Sixty-four in vivo fertilised
blastocysts were recovered at day 6 post-insemination (88.9%
related to ovulation rate, estimated as the number forming corpora
lutea).
Gene expression profiling and validation by real-time
qPCR
PCA showed that samples from the same group clustered
together (Figure 1). Analysis of expression data identified a total of
2541 differentially expressed transcripts between 6-day-old
parthenotes and in vivo fertilised embryos. Among these, 1185
were upregulated whereas the 1356 remaining transcripts were
downregulated. Table 2 shows a classification of differentially
expressed transcript probes based on fold-changes. Specifically,
parthenogenetic blastocysts exhibited changes in the expression of
92 genes, of which 16 had lower expression and 76 showed higher
expression than in vivo fertilised embryos using a minimal 3-fold
change as a cut-off. The lists of the upregulated and downregu-
lated genes in the parthenogenetic blastocysts are shown in Table 3
and 4, respectively.
All genes selected to validate the microarray analysis exhibited
expression patterns in line with previous results. Similarly, the
three genes that exhibited lower expression in parthenotes in the
microarray experiment (MPACT, DPY30 and CALC) also showed
decreased expression by RT-qPCR (Table 5), while three genes
showing higher expression in parthenogenetic blastocysts by the
microarray analysis (SCGB1A1, EMP1 and SMARCA2) also
Figure 3. Gene Ontology (GO) bar chart of differentially expressed genes between parthenotes and fertilised embryos. Gene
Ontology (GO) bar chart of differentially expressed genes between parthenotes and in vivo fertilised embryos. Genes upregulated and
downregulated in parthenotes embryos that are categorised by GO term ‘‘Molecular function’’ level 4.
doi:10.1371/journal.pone.0051271.g003
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exhibited increased expression by RT-qPCR (Table 5). Compar-
isons between fold-change of results for RT-qPCR and microarray
are shown in Table 5. The PCR experiments reproduced the
microarray profiling for selected genes, although fold changes
differed between RT-qPCR and microarray, which can be
explained by different probes used for RT-qPCR and microarray
[20].
Biological process, molecular function and cellular component
vocabulary items assigned to upregulated and downregulated
genes in parthenote embryos are shown in Figures 2, 3, and 4
respectively. For Biological Process, the most represented catego-
ries of altered genes were those related to cellular macromolecule
process, transport, regulation of cellular process, protein metabolic
process, nucleic acid metabolic process and macromolecule
modifications (Figure 2). As far as molecular function is concerned,
the most represented GO terms were DNA and RNA binding,
receptor binding and transferase activity (Figure 3). Finally, main
annotations for cellular components are those related to
mitochondrion, nuclear lumen, nucleus and cytoskeleton
(Figure 4).
Putatively imprinted genes
In parthenote embryos expression of paternally expressed
imprinted genes is not expected, since both alleles are of maternal
origin. We extracted information probes from the microarray data
that detected known or putative imprinted genes (Catalogue of
Imprinted Genes; http://igc.otago.ac.nz/home.html). Six of the
genes which appear as most specifically upregulated or downreg-
ulated in the microarray have previously been annotated as
imprinted genes. GRB10 and ATP10A were upregulated in
parthenotes, as expected because the maternal allele is the one
expressed, while ZNF215, NDN, IMPACT and SFMBT2 were
downregulated according to the paternal allele expression.
Furthermore, 26 other genes of the microarray which were
significantly different in parthenote embryos, also shown to have at
least one member of that gene family imprinted in other species
(Table 6).
Discussion
Our results demonstrated that parthenotes and in vivo fertilised
rabbit blastocysts cultured under in vivo conditions differ notably in
gene expression. Up till now, few works have analysed tran-
scriptome differences between parthenotes and fertilised embryos
Figure 4. Gene Ontology (GO) bar chart of differentially expressed genes between parthenotes and fertilised embryos. Gene
Ontology (GO) bar chart of differentially expressed genes between parthenotes and in vivo fertilised embryos. Genes upregulated and
downregulated in parthenotes embryos that are categorised by GO term ‘‘Cellular Component’’ level 7.
doi:10.1371/journal.pone.0051271.g004
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[20,21,22]. However, these works were carried out with
parthenote embryos developed in vitro and in vitro cultured fertilised
embryos. It is well documented that embryos developed under in
vitro environment are still not comparable with in vivo embryos
[23], as post-fertilisation culture environment is a determinant for
adequate embryonic development [4,24]. For example, one of the
most critical time points of preimplantation embryogenesis is the
major embryonic genome activation at which the embryo switches
from using the mRNA and proteins derived from the maternal
genome to those resulting from de novo transcription from the
embryonic genome [25]. During that time, availability of
transcription factors, which are regulated by cell cycle-dependent
mechanisms, is required [26]. These mechanisms are strongly
influenced by a change in environmental conditions and
subsequently affect the embryonic development, with potentially
severe effects on foetal, prenatal and postnatal viability [27].
Corcoran et al. [20] found that a total of 384 genes were
differentially expressed between in vivo and in vitro derived
blastocysts, the vast majority of them (almost 85%) being
downregulated in in vitro developed embryos. Likewise, the effects
of developmental environment on mRNA expression in parthe-
nogenetic embryos have also been described [11] this way. To our
best knowledge, this is the first report that compared the genome-
wide gene expression profiles between rabbit parthenogenetic
blastocysts and fertilised blastocysts developed in vivo.
Microarray analysis of parthenotes and fertilised embryos
developed in vitro indicated differences in expression of 749 genes
from mouse with 1.8 fold-changes as a cut-off [20], 24 genes for
early embryos and 5 for expanded embryos from bovine with 1.5
fold-changes as a cut-off [22] and 56 genes from buffalo with 1.4
fold-changes as a cut-off [21]. In this study, we observed that 1606,
557 and 199 microarray probe signals were changed in the
parthenogenetic blastocyst using a minimum of 1.5, 2.0 and 3.0
fold-changes as a cut-off, respectively. The 199 probe signals
represent 92 genes, of which 16 had lower expression and 76
showed higher expression in parthenotes than fertilised embryos,
developed in vivo. In the present study, in terms of biological
process categories, slight differences are observed between
transcript percentage of up and downregulated genes. However,
the main categories altered, related to transport and protein
metabolic process, comprise more upregulated than downregulat-
ed genes. Genes with high fold-changes such as BZND6, ANXAL,
MYL4 are involved in transport, while protein metabolic process
includes genes such as ClUS, PPIL6 or CIRL. In contrast, regarding
molecular function and cellular components, a higher percentage
of downregulated transcripts are comprised. In this case, the main
Table 6. Putative imprinted genes differentially expressed in parthenogenetic late blastocysts identified as family members at
Catalogue of Imprinted Genes (http://igc.otago.ac.nz/home.html).
Family members genes name
Imprinted gene Upregulated Downregulated
SLC22A2, SLC22A3, SLC22A8, SLC22A18S SLC22A5, SLC22A17
AWT1,WT1-AS SWT1
IGF2 IGF2BP2 IGF2BP3
RB1 RB11A
L3MBTL L3MBTL2 L3MBTL1
PPP1RGA PPP1CC
ASB4 ASB8 ASB3
KLF14 KLF16, KLF12 KLF3, KLF4
NAP1L5 NAP1L1
UPS29 USP2, USP4, USP25, USP53 USP7, USP15, USP22, USP28, USP34USP40, USP43, USP46, USP48
ZFP264, ZFP127 ZFP36, ZFP57, ZFP62, ZFP90
PEC2, PEC3 PECR
NCCR NCCRP1
UBE3A UBE3B, UBE4B
TSPAN32 TSPAN5, TSPAN12, TSPAN13 TSPAN1N, TSPAN14, TSPAN31
TNFRSF23 TNFRSF1A
ANO1 ANO6
INPP5F-V2 INPP1, INPP4B
RASGRF1 RASGEF1B, RASGRP3 RASGRP1, RASGRP2
COMMD1 COMMD3, COMMD5 COMMD2, COMMD7, COMMD8
HTR2A HTRA4
FBXO40 FBXO15, FBXO32, FBXO48 FBXO4, FBXO5, FBXO25, FBXO38, FBXO42
SNRPN SNRPPA1, SNRPB2
PRIM2 PRIM1
CDKN1C CDKN1A, CDKN1B, CDKN3
SASH2 SASH1
doi:10.1371/journal.pone.0051271.t006
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altered categories are those related to DNA and RNA binding,
both located in cellular nucleus and involving genes such as
GTF2B (general transcription initiation factor IIb; X), CHURC1
(Churchill domain containing 1), XRCC2 (DNA repair protein
XRCC2), HNRNPD (heterogeneous nuclear ribonucleoprotein D),
SAFB2 (scaffold attachment factor B2) or NEIL3 (nei endonuclease
VIII-like 3) among others. So, these results suggest a great
deficiency of the machinery associated with transcription and
translation which might hinder basic cell functioning and thereby
pre-implantatory development of parthenogenotes. Similar results
of the main categories altered in biological processes have been
observed before in gene expression profile studies of in vitro
developed parthenotes. Processes such as proteolysis, peptidolysis,
protein amino acid phosphorylation and cell transport showed to
be the most representative upregulated in parthenotes, while
nucleic acid binding and metabolic process were representative of
the higher percentage of donwregulated transcripts in parthenotes
[20,21].
To date, more than 100 imprinted genes have been identified in
mice and many of them are also imprinted in humans [29]. In
livestock animals, imprinted genes have also been identified
[30,31,32,33]. However, to our best knowledge, few genes have
been identified as subject to genomic imprinting in rabbit. All
imprinted genes show either maternal-specific or paternal-specific
mono-allelic expression, and their proper expression is essential for
normal development, foetal growth, nutrient metabolism and
adult behaviour [34]. We extracted informative probes from the
microarray data that detected known or putative imprinted genes
(Catalogue of Imprinted Genes; http://igc.otago.ac.nz/home.
html). Of the 32 putative genes analysed in this manner (table 6),
6 were identified as conserved between rabbits, humans and mice;
they included GRB10, ATP10A, ZNF215, NDN, IMPACT and
SFMBT2. GRB10, SNRPN and CDKN1 were also shown to be
imprinted in a previous work carried out with in vitro developed
parthenotes in mouse [20]. In fact, the use of microarrays to
analyse imprinted genes provided results in the same direction as
quantitative allelic pyrosequencing (QUASEP) analysis [30].
In conclusion, the resulting findings of this study revealed that
even under the best developmental conditions, parthenogenetic
and fertilised embryos at the late blastocyst stage are different, with
at least 92 genes significantly and differentially expressed. These
differences have been shown to affect basic functions such as DNA
and RNA binding, nucleus, mitochondrion and transport, among
others. ESCs may inherit the blastocyst level of transcripts, and the
alterations observed in parthenogenetic embryos could therefore
be maintained in pESCs derived from them. These alterations in
gene expression call for further studies to evaluate whether and to
what extent these modifications are unfavourable for ESC
establishment and successive transplantation therapies. Further-
more, this work represents the first approach to the study of
imprinted genes in rabbit. Hence, future research into imprinted
genes might also include rabbits as alternative model systems.
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